No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
NBY NovaBay Pharmaceuticals
- 0.5299
- +0.0258+5.12%
Close Dec 20 16:00 ET
- 0.5100
- -0.0199-3.76%
Post 19:59 ET
2.59MMarket Cap-0.01P/E (TTM)
0.5299High0.5046Low597.91KVolume0.5166Open0.5041Pre Close360.74KTurnover12.25%Turnover Ratio0.00P/E (Static)4.89MShares9.079052wk High2.43P/B2.59MFloat Cap0.361152wk Low--Dividend TTM4.88MShs Float130156.1979Historical High--Div YieldTTM5.02%Amplitude0.3610Historical Low0.6030Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting
NovaBay Pharmaceuticals To Reconvene Special Meeting Of Stockholders To December 18, 2024; Initial Meeting Adjourned Due To Insufficient Votes To Reach The 50% Threshold Of Outstanding Common Shares Voting In Favor Of Proposal One And Two
Express News | NovaBay Pharmaceuticals: Iss Supports Co's Proposals to Authorize Sale of Its Avenova Brand
Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of Its Avenova Brand
NovaBay Pharmaceuticals Reports Q3 2024 Financials Amid Strategic Changes
Ascendiant Capital Maintains Buy on NovaBay Pharmaceuticals, Adjusts Price Target To $0.85 (1-35 Reverse Stock Split)
Heat List
US
Overall
Symbol
Price
% Chg
No Data